Merck Deepens Oncology and Vaccine Bets with Partnerships and Equity Stake

Merck has strengthened its presence in oncology and vaccines through partnerships and equity stakes, including a significant stake in Eikon Therapeutics and a global oncology collaboration with Guardant Health. The company is also improving global access to Zaire ebolavirus vaccines. These moves reflect Merck's core areas in cancer and vaccines and highlight its commitment to precision treatment approaches and global health. The company's capital allocation mix includes minority investments and alliances to extend its reach while maintaining a measured near-term outlook.